ArticleScience advances2025
Accelerated design of gold nanoparticles with enhanced plasmonic performance.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Seeing Beyond RGB Capabilities: Data-Driven and Physics-Guided Broadband Spectral Extrapolation of Plasmonic Nanostructures by Deep Learning.ACS photonics · 2026Article
- Living Inorganic Nanomaterials: Design, Preparation, and Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Research Progress on Material, Preparation, Properties, and Water Purification Applications of Solar Energy-Driven Hydrogels.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Controlling Nanoscale Heat With Optically Coupled Plasmonic Systems.Nanophotonics (Berlin, Germany) · 2026Article
- Gold bipyramids as a promising alternative to gold nanorods for analytical and biomedical applications.Beilstein journal of nanotechnology · 2026Article
- Plasmonic Metal Nanoparticles in Sensing Applications: From Synthesis to Implementations in Biochemical and Medical Diagnostics.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Finding the optimal dimensions of metal nanoparticles to maximize their plasmonic performance in targeted applications is a complex and time-consuming process that typically requires a trial-and-error approach. Here, we propose a universal pipeline that integrates Bayesian optimization with electrodynamics simulations to find dimensions of gold bipyramids with superior plasmonic performance in photothermal efficiency, enhancement of Raman scattering and photoluminescence, strong coupling between plasmon and exciton, and aggregation-induced color difference. Our workflow is a straightforward tool for plasmonic nanoparticle design, setting their optimal dimensions for targeted applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.